A novel human IFN- alpha subtype having a high specific activity unknown hitherto and its derivative; DNAs encoding these proteins; expression vectors having these DNAs; transformants transformed by these expression vectors; a process for producing the above-mentioned human IFN- alpha and its derivative; and medicinal use of the human IFN- alpha and its derivative.
